Contagiousness of smear negative TB?

>
By  |  November 20, 2008 | 

Smear negative TB patients are thought to be much less contagious than smear positive patients, but how much so? In this retrospective analysis from the Netherlands using a national DNA fingerprint database, researchers determined 13% of secondary TB cases were attributable to smear negative patients, and that the relative transmission of smear negative, compared to smear positive, patients was 0.24. This study implies that the “no-isolation needed” hospital standard for smear negative TB patients needs to be re-visited, and that the risk of transmission of smear negative patients is less than smear positive, but certainly not insubstantial (abstract)

Share This Post

2 Comments

  1. Jogesh Raja November 20, 2008 at 9:30 pm - Reply

    What is the reliability of sputum collection? Was sputum subjected to MTB PCR DNA testing to see if we missed true sputum negative cases? It is also possible that these patients were sputum negative when tested and became sputum positive later when the TB lesion had breakdown. Does this mean that when we have a patient with proven TB and his/her sputum is negative we should still isolate them and for how long? What happens when we discharge them to community? What advise should we give to protect the community at large and for hoe long he should follow this advise?

  2. Danielle November 25, 2008 at 2:44 pm - Reply

    Great questions posed here. It is a matter of weighing the risk to the patient (of isolation) versus the public health risk of transmission. It is certainly plausible that patients could be intermittantly contagious (such as you suggested); I think the public health community has never posed that a cross-sectional smear-negative patient can never again be contagious. But, this is the first well done study to attempt to quantify what proportion of new TB cases are contracted from “smear negative” patients, and the number is higher than I think anyone expected to see.

Leave A Comment

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

About the Author: Danielle Scheurer

Danielle Scheurer, MD, MSCR, SFHM is a clinical hospitalist and the Chief Quality Officer at the Medical University of South Carolina in Charleston, South Carolina, where she also serves as Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She is also the President of SHM's Board of Directors and previously served as Physician Editor of The Hospitalist, SHM's monthly newsmagazine.

Categories

Related Posts

By Dhaval Desai, MD
August 17, 2021 |  5
During the first two to three weeks of the pandemic in 2020, I was involved in a lot of meetings about the current status and future plans for the impending surge of COVID-19 patients we were anticipating. It was during that time we witnessed COVID-19 ravaging cities like New York City. In one of the […]
By Swati Mehta, MD, FACP
April 9, 2021 |  1
The COVID-19 pandemic has changed health care as we know it. It has sowed fear and doubt among the public and created endless questions without answers. Our hospitalized patients may wonder why they can’t have their families beside them and worry about contracting the virus in the hospital. Strict visitation policies only add to their […]
By Saurin Gandhi DO, Kristin Mondy MD, Johanna Busch MD, W. Michael Brode MD
April 7, 2021 |  0
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. During the early months of the COVID-19 […]
Go to Top